The polymeric nanoparticles increased the antitumor effect of Sali in ovarian cancer, and moreover, the antibody-modified nanoparticles were more capable of eradicating the ovarian CSC population than the controls, upon binding to the CD133 surface marker [74]. Here, PROM1 is linked to ovarian carcinoma.